About Gary Sender
Form D filings for Elucida Oncology from 2022 to 2023 list Gary Sender as director.
Gary Sender first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Gary Sender in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gary Sender works with at each company, as listed on that company's latest Form D.
Elucida Oncology, Inc. · Form D/A, Aug 3, 2023
TB
Tim Boris
Director
RR
Robert Ruffolo
Director
DZ
David Zacardelli
Director
UW
Ulrich Wiesner
Director
RE
Robert Essner
Executive officer and director
NM
Natalie MacDonald
Director
GG
Geno Germano
CEO and director